Navigation Links
In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
Date:2/20/2008

Following its Approval, Erbitux Will Earn Gold-Standard Status in 2011,

According to a New Report from Decision Resources

WALTHAM, Mass., Feb. 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on overall survival is the attribute that most influences oncologists' prescribing decisions in the treatment of stage III colon cancer. Clinical data and expert opinion shows that Bristol-Myers Squibb/ImClone Systems/Merck KGaA's Erbitux and Roche/Genentech/Chugai's Avastin have advantages in this attribute when used in combination with sales-leading FOLFOX4 treatment. FOLFOX4 is comprised of oxaliplatin (Sanofi-Aventis's Eloxatin/Eloxatine, Yakult's Elplat), 5- fluorouracil and leucovorin.

The new report entitled Colon Cancer (Stage III): Therapies Must Increase Survival over FOLFOX to Reach Blockbuster Status finds that surveyed oncologists indicate that a therapy which improves disease-free survival over FOLFOX4 at three years would earn a 60% patient share and achieve blockbuster status. The report forecasts that Avastin, in combination with FOLFOX4, will earn a 22% patient share in the U.S. stage III colon cancer market in 2016. Additionally, owing to its efficacy, safety and tolerability, Erbitux in combination with FOLFOX4 will earn gold-standard status for stage III colon cancer in 2011, following its approval for the indication in 2010 in the U.S. and Europe.

"When using both drugs in combination with FOLFOX4, experts gave Erbitux a slightly higher score over Avastin in safety and tolerability," said Marcus Hoyle, analyst at Decision Resources. "Oncologists indicated that the cardiovascular toxicity associated with VEGF inhibitors, such as Avastin, has a more negative impact on their prescribing decisions than the tissue disorders associated with EGFR inhibitors, such as Erbitux."

About the Report '/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Combination of Thyroid Medicines Not Necessary
2. Combination therapy improves survival for certain prostate cancer patients
3. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
4. Drug combination shrinks breast cancer metastases in brain
5. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
6. 3-drug combination extremely promising as first-line therapy for multiple myeloma
7. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
8. ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity
9. Drug combination effective against multiple myeloma, researchers show
10. HIV drug resistance risk in mothers reduced by combination of common drugs
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... HR Consulting firm CPEhr, and Junior Achi...hadow Day for 30 high-students from Downtown Busin...cs such as labor law, interviewing techniques and ...f. (PRWEB) July 24, 2008 -- Los Angeles HR Consul...ofit organization, hosted a Job Shadow Day for 30 ...
(Date:7/24/2008)... As America's baby boomers age, more ...s such as diabetes that necessitate the use of med...celet jewelry gives a generation attractive incent...n. , (PRWEB) July 24, 200...g health conditions can make a statement in more w...
(Date:7/23/2008)... N.Y., July 24 /PRNewswire/ -- MediVoice(R), LLC, ... for e-Health and,e-Prescribing, has formed a stra...ovider of interactive, web-based, patient-centered...on systems to integrate and market its,mobile voic...Care(TM),(VTOC) system., "MediVoice is pleased to...
(Date:7/23/2008)...roblem For 10+ Years Even Though Some Kilns Emit M...ement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, OR,...e-USNewswire/ -- For more than a decade,after Cong...rom cement,kilns across the nation, the U.S. Envir...ction. Now, a new study from Earthjustice and the,...
Breaking Medicine News(10 mins):Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
...that a migraine headache decreases over the years.... painful and do not last much long. These findin...he Society annual meeting in Chicago, by Carl Dahl...dical director and founder of the Gothenburg Migra...
...act that will be presented Monday at SLEEP 2007, a...d toddlers born prematurely occurs earlier than e...an among full-term infants. The study, authored b...f West Virginia University, consisted of the respo...
...gh, who was admitted to a hospital in East Delhi a...y raising speculations of a suicide attempt by hi... In a statement to the Delhi Police, Singh said th...e glass window panes broke when he banged his hand...
...worry about the ticking of their biological clocks...rugs that could delay menopause. The news was br...who told a press conference that researchers had f...uld be soon be developed into a pill or an injecti...
Other Medicine News:Health News:Ages Eases the Pain of Migraine 2Health News:Scientists Have Found Way to Delay Menopause 2
(Date:7/21/2008)...ical Trials Management, WASHINGTON, July 21 /PRNe...Health Centers (AAHC) today launched a new Clinica... academic health center leaders,research administ...ing,strengthening, and improving the administrati...ticularly to manage and support compliance,functio...
(Date:7/21/2008)... in Italy continue, FRANKLIN, Mass., July 21 /PRN... ) announced today that it will defer the commence...M) System in the prevention of,Contrast-Induced Ne...the,investigator-sponsored clinical trial now ongo...launch of RenalGuard in Europe, which began in the...
(Date:7/21/2008)...Call/ -- Alfacell Corporation,(Nasdaq: ACEL ) tod...ancer,Therapeutics (2008; 7(7):1871-9) reports tha...hiazolidinedione antidiabetic drug rosiglitazone,s... expression of,PI3K-dependent Fra-1 expression or ...in vitro research conducted at,the University of V...
(Date:7/18/2008)... Velcura Therapeutics, Inc.,CEO Michael Long, Ph.D...d,the Board of Directors of the biotechnology comp... for VEL-0230, a powerful anti-inflammatory,agent ...s. Velcura is,investigating its lead compound as a... diseases., Bill Brinkerhoff is the chief operati...
Breaking Medicine Technology:New AAHC Toolkit Available to Optimize Clinical Research Administration 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 2Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 3Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors 2ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office 951 1ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office 951 2European Union has Three Speed Healthcare System Many Countries Lagging in Reform 948 1European Union has Three Speed Healthcare System Many Countries Lagging in Reform 948 2Abiant Inc Announces Close on Investment Round 945 1Abiant Inc Announces Close on Investment Round 945 2Taxotere 28R 29 28docetaxel 29 Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 412 1Taxotere 28R 29 28docetaxel 29 Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 412 2Taxotere 28R 29 28docetaxel 29 Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 412 3Taxotere 28R 29 28docetaxel 29 Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 412 4
...all/ -- Bioponic,Phytoceuticals, Inc. ("Bioponic" ...in(TM) (a Bioresonant Phytotherapeutic(R) form of,...ivery system) may,be an important treatment for Lu...e Direct, "Induction of,Apoptosis in Human Lung Ca...nt of Medicine, Pediatrics and Family and Preventi...
...Afid,Therapeutics, Inc. announced that it received... mode viral sequestration agents to,block viral in...ere,obtained from a specialized, independent third...rating agents are designed to,bind and inactivate ...ection. They are aimed at viruses responsible for ...
Other Medicine Technology:Curecumin May Be an Effective Treatment for Lung Cancer 2Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
Medicine Products: